News
The Spanish Medicines Market Today
9 February 2011
Spending by Spain’s National Health Service (NHS) on pharmaceuticals was €12.1 billion in 2010. Its market for prescription medicines is among the slowest growing in Europe,…
Exploring Local NHS Decisions about Investment
4 February 2011
OHE is pleased to welcome Jamie Garside to the team. Jamie recently graduated with an MSc in health economics (with Distinction) from City University London.
Comparing Variants of Lead and Lag Time TTO
1 February 2011
OHE was awarded a UK Department of Health grant to further develop three aspects of health status indexes. Results of the second of these, advances in…
The Market for Biosimilars
25 January 2011
This publication expands on the series of posts published earlier on this blog. It reports on a seminar intended to encourage further thought about the distinguishing…
Economic Evidence and NHS Reforms in England
19 January 2011
OHE collaborated with the Centre for Health Economics of the University of York in hosting workshop for policy makers and their advisers on NHS reforms. Discussion…
Update: Value-Based Pricing in the UK
11 January 2011
Value-based pricing for new medicines, proposed as part of UK health care reform, would create a QALY-plus approach for drugs approved starting 1 January 2014. For…
Measuring Value: OHE at ISPOR
4 January 2011
Members of the OHE team participated in a number of sessions at ISPOR’s 13th Annual European Congress in November. This post summarizes the contributions of Prof…
Seminar Briefing on Science Policy
23 December 2010
At a recent OHE seminar, Prof Ben Martin (Science and Technology Policy Studies at SPRU, University of Sussex) presented the results of his extensive literature review…
Report on Orphan Drugs Released
9 December 2010
OHE Consulting has released new research on orphan medicinal products (OMPs) in Europe that assesses the effects of the European Union’s 1999 Regulation on Orphan Medicinal…